The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Computational Science, 2017Analyzing Data from the Parkinson’s Progression Markers Initiative to Identify Subtypes of Parkinson’s Disease
Study Rationale:
Parkinson's disease (PD) presents and progresses variably, so no two people with Parkinson's have the same disease. The diversity of PD clinical manifestations makes the disease more... -
Computational Science, 2017Complex Data Analysis for the Development of Parkinson’s Disease Biomarkers
Study Design:
To test this hypothesis, we will employ recent discoveries in computer science, PD biomarker research and standardized sets of PD data. First, we will develop machine-learning techniques... -
Therapeutic Pipeline Program, 2017Alternative Brain Stimulation Approach for the Treatment of Swallowing Impairment in Parkinson’s Disease
Study Rationale:
Dysphagia -- difficulty swallowing -- is common in people with advanced Parkinson's disease (PD). Dysphagia often leads to aspiration -- inhaling of food -- which can result in... -
Target Advancement Program, 2017Synapsin III as a Novel Therapeutic Target in Parkinson's Disease
Promising Outcomes of Original Grant:
Although the role of alpha-synuclein, the sticky protein that clumps in the cells of people with Parkinson's disease (PD), is not entirely clear, it is believed to... -
Research Grant, 2017A Study of Gastrointestinal Impairment in Parkinson's Disease
Study Rationale:
Gastrointestinal (GI) symptoms, such as constipation, nausea and vomiting, are common in Parkinson's disease (PD), but the cause of these symptoms is not entirely clear. Slow movement... -
Research Grant, 2017Studying Alpha-synuclein Oligomers Using Oligomer-binding Antibodies
Study Rationale:
Alpha-synuclein, the sticky protein that clumps in the cells of people with Parkinson's disease (PD), has long been implicated in the development of PD. Alpha-synuclein clumps vary in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.